{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T09:15:19Z","timestamp":1759482919185},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,11,27]],"date-time":"2008-11-27T00:00:00Z","timestamp":1227744000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1007\/s11255-008-9497-6","type":"journal-article","created":{"date-parts":[[2008,11,26]],"date-time":"2008-11-26T12:33:51Z","timestamp":1227702831000},"page":"913-918","source":"Crossref","is-referenced-by-count":12,"title":["Niacin and analogs for phosphate control in dialysis\u2014perspective from a developing country"],"prefix":"10.1007","volume":"41","author":[{"given":"Krishnaswamy","family":"Sampathkumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,11,27]]},"reference":[{"issue":"4","key":"9497_CR1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ajcn\/31.4.558","volume":"31","author":"DF Miller","year":"1978","unstructured":"Miller DF (1978) Pellagra deaths in the United States. Am J Clin Nutr 31(4):558\u2013559","journal-title":"Am J Clin Nutr"},{"key":"9497_CR2","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/0003-9861(55)90070-9","volume":"54","author":"R Altschul","year":"1955","unstructured":"Altschul R, Hoffer A, Stephen JD (1955) Influence of nicotinic acid on serum cholesterol in man. Arch Biochem 54:558\u2013559. doi: 10.1016\/0003-9861(55)90070-9","journal-title":"Arch Biochem"},{"key":"9497_CR3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","volume":"16","author":"RN Foley","year":"2005","unstructured":"Foley RN, Murray AM, Li S (2005) Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the united states medicare population, 1998 to 1999. J Am Soc Nephrol 16:489\u2013495. doi: 10.1681\/ASN.2004030203","journal-title":"J Am Soc Nephrol"},{"key":"9497_CR4","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","volume":"15","author":"GA Block","year":"2004","unstructured":"Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15:2208\u20132218. doi: 10.1097\/01.ASN.0000133041.27682.A2","journal-title":"J Am Soc Nephrol"},{"issue":"Supl. 3","key":"9497_CR5","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.1016\/S0272-6386(04)01103-5","volume":"44","author":"EW Young","year":"2004","unstructured":"Young EW, Akiba T, Albert J (2004) Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the dialysis outcomes and practice patterns study (DOPPS). Am J Kidney Dis 44(Supl. 3):S34\u2013S38","journal-title":"Am J Kidney Dis"},{"key":"9497_CR6","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1681\/ASN.2004070602","volume":"16","author":"B Kestenbaum","year":"2004","unstructured":"Kestenbaum B, Sampson JN, Rudser KD (2004) Serum phosphate levels and mortality risk among people with chronic kidney disease. J Am Soc Nephrol 16:520\u2013528. doi: 10.1681\/ASN.2004070602","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"9497_CR7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1492-7535.2005.01119.x","volume":"Jan; 9","author":"S Sankarasubbaiyan","year":"2005","unstructured":"Sankarasubbaiyan S, Abraham G, Soundararajan P et al (2005) Parathyroid hormone and biochemical profile in chronic kidney disease patients in South India. Hemodial Int Jan; 9(1):63\u201367","journal-title":"Hemodial Int"},{"issue":"5","key":"9497_CR8","first-page":"236","volume":"33","author":"S Tomasellow","year":"2004","unstructured":"Tomasellow S, Dhupar S, Sherman RA (2004) Phosphate binders, K\/DOQI guidelines and compliance: the unfortunate reality. Dial Transplant 33(5):236\u2013240","journal-title":"Dial Transplant"},{"key":"9497_CR9","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11255-007-9300-0","volume":"40","author":"IP Tzanakis","year":"2008","unstructured":"Tzanakis IP, Papadaki AN, Wei M et al (2008) Magnesium carbonate for phosphate control for patients on hemodialysis randomized controlled trial. Int Urol Nephrol 40:193\u2013201. doi: 10.1007\/s11255-007-9300-0","journal-title":"Int Urol Nephrol"},{"key":"9497_CR10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1046\/j.1523-1755.2002.00434.x","volume":"62","author":"GM Chertow","year":"2002","unstructured":"Chertow GM, Burke SK, Raggi P (2002) Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 62:245\u2013252. doi: 10.1046\/j.1523-1755.2002.00434.x","journal-title":"Kidney Int"},{"key":"9497_CR11","doi-asserted-by":"crossref","unstructured":"Berns JS (2008). Niacin and related compounds for treating hyperphosphatemia in dialysis patients. Semin Dial 21(3):203\u2013205. doi: 10.1111\/j.1525-139X.2008.00426.x","DOI":"10.1111\/j.1525-139X.2008.00426.x"},{"key":"9497_CR12","first-page":"1","volume":"40","author":"K Shimoda","year":"1998","unstructured":"Shimoda K, Akiba T, Matsushima T, Rai T et al (1998) Niceriotol decreases serum phosphate levels in chronic hemodialysis patients. Nippon Jinzo Gakkai Shi 40:1\u20137","journal-title":"Nippon Jinzo Gakkai Shi"},{"key":"9497_CR13","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1093\/ndt\/14.3.610","volume":"14","author":"N Kuboyama","year":"1999","unstructured":"Kuboyama N, Watanabe Y, Yamaguchi M, Sato K, Suzuki T, Akiba T (1999) Effects of niceritol on faecal and urinary phosphate excretion in normal rats. Nephrol Dial Transplant 14:610\u2013614. doi: 10.1093\/ndt\/14.3.610","journal-title":"Nephrol Dial Transplant"},{"key":"9497_CR14","doi-asserted-by":"crossref","first-page":"14564","DOI":"10.1073\/pnas.95.24.14564","volume":"95","author":"H Hilfiker","year":"1998","unstructured":"Hilfiker H, Hattenhauer O, Murer H et al (1998) Characterization of a murine type II sodium\u2013phosphate cotransporter expressed in mammalian small intestine. Proc Natl Acad Sci USA 95:14564\u201314569. doi: 10.1073\/pnas.95.24.14564","journal-title":"Proc Natl Acad Sci USA"},{"key":"9497_CR15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.nutr.25.050304.092642","volume":"25","author":"HS Tenenhouse","year":"2005","unstructured":"Tenenhouse HS (2005) Regulation of phosphorus homeostasis by the type IIa Na\/phosphate cotransporter. Annu Rev Nutr 25:197\u2013214. doi: 10.1146\/annurev.nutr.25.050304.092642","journal-title":"Annu Rev Nutr"},{"key":"9497_CR16","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1093\/ndt\/gfh781","volume":"20","author":"N Eto","year":"2005","unstructured":"Eto N, Miyata Y, Ohno H, Yamashita T (2005) Nicotinamide prevents the development of hyperphosphatemia by suppressing the intestinal sodium dependent phosphate transporter in rats with adenine induced renal failure. Nephrol Dial Transplant 20:1378\u20131384. doi: 10.1093\/ndt\/gfh781","journal-title":"Nephrol Dial Transplant"},{"key":"9497_CR17","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/j.1523-1755.2004.00482.x","volume":"65","author":"Y Takahashi","year":"2004","unstructured":"Takahashi Y, Tanaka A et al (2004) Nicotinamide suppresses hyperphosphatemia in hemodialysis patients. Kidney Int 65:1099\u20131104","journal-title":"Kidney Int"},{"key":"9497_CR18","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11255-006-0001-x","volume":"38","author":"K Sampathkumar","year":"2006","unstructured":"Sampathkumar K, Selvam M, Sooraj Y, Gowthaman S, Ajeshkumar R (2006) Extended release nicotinic acid is a novel agent for Phosphate control in dialysis. Int Urol Nephrol 38:171\u2013174. doi: 10.1007\/s11255-006-0001-x","journal-title":"Int Urol Nephrol"},{"key":"9497_CR19","unstructured":"Sampathkumar K, Sooraj Y, Mahaldar AR (2007) Comparative efficacy of low dose nicotinic acid and Lanthanum in lowering the Phosphorus levels in hemodialysis patients. S-PO-0327-Paper presented at WCN 2007, Rio de Janeiro, Brazil"},{"key":"9497_CR20","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2215\/CJN.01470307","volume":"2","author":"D M\u00fcller","year":"2007","unstructured":"M\u00fcller D, Mehling H et al (2007) Niacin lowers serum phosphate and increases HDL cholesterol in dialysis patients. Clin J Am Soc Nephrol 2:1249\u20131254. doi: 10.2215\/CJN.01470307","journal-title":"Clin J Am Soc Nephrol"},{"key":"9497_CR21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04211007","volume":"3","author":"SC Cheng","year":"2008","unstructured":"Cheng SC, Young DO (2008) A Randomized, double-blind, placebo-controlled trial of Niacinamide for reduction of Phosphorus in hemodialysis patients. Clin J Am Soc Nephrol 3:1131\u20131138. doi: 10.2215\/CJN.04211007","journal-title":"Clin J Am Soc Nephrol"},{"key":"9497_CR22","unstructured":"Musso CG, Reynaldi MJ, Aparicio C et\u00a0al. (2007) Hyperphosphatemia and nicotinic acid in peritoneal dialysis patients. Int Urol Nephrol 229\u2013230"},{"issue":"1","key":"9497_CR23","first-page":"61","volume":"28","author":"A Restrepo Valencia","year":"2008","unstructured":"Restrepo Valencia A, Cruz J (2008) Safety and effectiveness of nicotinic acid in the management of patients with chronic renal disease and hyperlipidemia associated to hyperphosphatemia C. Nefrolog\u00eda 28(1):61\u201366","journal-title":"Nefrolog\u00eda"},{"key":"9497_CR24","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/S0140-6736(04)16359-9","volume":"363","author":"F Karpe","year":"2004","unstructured":"Karpe F, Frayn KN (2004) The nicotinic acid receptor\u2014a new mechanism for an old drug. Lancet 363:1892\u20131894. doi: 10.1016\/S0140-6736(04)16359-9","journal-title":"Lancet"},{"issue":"6","key":"9497_CR25","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/ki.1997.260","volume":"51","author":"LG Hunsicker","year":"1997","unstructured":"Hunsicker LG, Adler S, Caggiula A et al (1997) Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51(6):1908\u20131919. doi: 10.1038\/ki.1997.260","journal-title":"Kidney Int"},{"issue":"4","key":"9497_CR26","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1161\/01.HYP.26.4.670","volume":"26","author":"M Manttari","year":"1995","unstructured":"Manttari M, Tiula E, Alikoski T, Manninen V (1995) Effects of hypertension and dyslipidaemia on the decline in renal function. Hypertension 26(4):670\u2013675","journal-title":"Hypertension"},{"issue":"2","key":"9497_CR27","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ijcard.2003.11.003","volume":"97","author":"R Gupta","year":"2004","unstructured":"Gupta R, Deedwania PC, Gupta A, Rastogi S, Panwar RB, Kothari K (2004) Prevalence of metabolic syndrome in an Indian urban population. Int J Cardiol 97(2):257\u2013261. doi: 10.1016\/j.ijcard.2003.11.003","journal-title":"Int J Cardiol"},{"issue":"3","key":"9497_CR28","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0168-8227(03)00060-3","volume":"Jun;60","author":"A Ramachandran","year":"2003","unstructured":"Ramachandran A, Snehalatha C, Satyavani K, Sivasankari S, Vijay V (2003) Metabolic syndrome in urban Asian Indian adults\u2014a population study using modified ATP III criteria. Diabetes Res Clin Pract Jun;60(3):199\u2013204","journal-title":"Diabetes Res Clin Pract"},{"key":"9497_CR29","first-page":"1746","volume":"366","author":"KS Reddy","year":"2005","unstructured":"Reddy KS, Shah B, Varghese C, Ramadoss A (2005) Responding to the threat of chronic diseases in India. Lancet 366:1746\u20131751","journal-title":"Lancet"},{"key":"9497_CR30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1007\/s11255-006-9162-x","volume":"39","author":"H Abo-zenah","year":"2007","unstructured":"Abo-zenah H, Sabry A, Farouk A et al (2007) Impact of hemodialysis associated variables in lipid profiles in Egyptian hemodialysis population. Int Urol Nephrol 39:609\u2013618. doi: 10.1007\/s11255-006-9162-x","journal-title":"Int Urol Nephrol"},{"key":"9497_CR31","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1038\/sj.ki.5001979","volume":"70","author":"GA Kaysen","year":"2006","unstructured":"Kaysen GA (2006) Dyslipidemia in chronic kidney disease: causes and consequences. Kidney Int 70:S55\u2013S58","journal-title":"Kidney Int"},{"key":"9497_CR32","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1172\/JCI109385","volume":"63","author":"J Sheherd","year":"1979","unstructured":"Sheherd J, Packard CJ, Patsch JR et al (1979) Effects of nicotinic acid therapy on plasma high density lipoprotein subfraction distribution and composition and on apolipoprotein A metabolism. J Clin Invest 63:858\u2013867. doi: 10.1172\/JCI109385","journal-title":"J Clin Invest"},{"key":"9497_CR33","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1111\/j.1523-1755.2005.00583_8.x","volume":"68","author":"JB Rottembourg","year":"2005","unstructured":"Rottembourg JB, Launay\u2013Vacher V, Massard J (2005) Thrombocytopenia induced by nicotinamide in hemodialysis patients. Kidney Int 68:2911\u20132912. doi: 10.1111\/j.1523-1755.2005.00583_8.x","journal-title":"Kidney Int"},{"key":"9497_CR34","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0025-6196(12)60393-0","volume":"67","author":"T O\u2019Brien","year":"1992","unstructured":"O\u2019Brien T, Silverberg J, Nguyen T (1992) Nicotinic acid-induced toxicity associated with cytopenia and decreased level of thyroxin-binding globulin. Mayo Clin Proc 67:465\u2013468","journal-title":"Mayo Clin Proc"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-008-9497-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-008-9497-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-008-9497-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T07:55:27Z","timestamp":1559375727000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-008-9497-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11,27]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["9497"],"URL":"https:\/\/doi.org\/10.1007\/s11255-008-9497-6","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,11,27]]}}}